logo-loader

UPDATE - Kromek sees greater demand

Published: 09:36 28 Aug 2014 EDT

hospital_350_53fef06e662c4

--Adds broker comment--

Kromek (LON:KMK) revealed it is seeing greater demand for its products.

The technology firm in today’s results, for the twelve months to April 30, highlighted multiple significant contract wins in the medical imaging market and agreements to supply imaging modules to China.

It also agreed contracts with both commercial and government customers for nuclear detection.

"The appetite for Kromek's components, systems and solutions in each of our target markets is increasing,” said chief executive Arnab Basu.

“The group is well placed, not only to continue to win new contracts, but also to service the growing demand for our technologies and achieve our ambition of becoming the radiation detection specialists of choice in our chosen markets.

“We have reported a number of new contracts post this period end and we are continuing to convert a strong pipeline with the current order book at an all-time high."

Panmure Gordon analyst Dr Mike Mitchell said Kromek performed ‘in line’ as he upgraded his recommendation to ‘buy’ from ‘hold.

In a note the analyst said: “While a business such as Kromek will always be subject to some element of temporal risk (such as timing on government expenditure), we believe the broader commercial positioning and a greater emphasis on budgeting/planning stands the business in good stead.”

On AIM, Kromek shares moved 0.4p (0.8%) lower at 50.1p.

BP led the way on the markets, following other major energy companies in...

FTSE 100 remained relatively flat in early trading, up 6 points to 7,420. Unsurprisingly, BP led the way as it followed other oil & gas and energy companies in posting bumper results. It said its profits more than tripled in the second quarter amidst peak oil and gas prices. Dividends...

on 08/02/2022